Bio-Techne Corp Company Profile (NASDAQ:TECH)

About Bio-Techne Corp (NASDAQ:TECH)

Bio-Techne Corp logoBio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products, such as cytokines, growth factors, immunoassays, antibodies and related reagents, across the world. The Clinical Controls segment develops and manufactures controls, calibrators, immunoassays and other reagents for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis. It markets immunoassays on different testing platforms, including microtiter-plate based kits sold under the trade name Quantikine, and immunoassays based on planar spotted surfaces and microfluidic-based multiplex immunoassays on automated testing platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:TECH
  • CUSIP: 87837710
  • Web: www.techne-corp.com
Capitalization:
  • Market Cap: $4.54627 billion
  • Outstanding Shares: 37,382,000
Average Prices:
  • 50 Day Moving Avg: $119.11
  • 200 Day Moving Avg: $112.10
  • 52 Week Range: $95.68 - $124.00
P/E:
  • Trailing P/E Ratio: 59.96
  • Foreward P/E Ratio: 29.69
  • P/E Growth: 2.97
Sales & Book Value:
  • Annual Revenue: $563 million
  • Price / Sales: 8.08
  • Book Value: $25.42 per share
  • Price / Book: 4.79
Dividend:
  • Annual Dividend: $1.28
  • Dividend Yield: 1.1%
Profitability:
  • EBIDTA: $186.35 million
  • Net Margins: 12.93%
  • Return on Equity: 14.19%
  • Return on Assets: 8.43%
Debt:
  • Debt-to-Equity Ratio: 0.36%
  • Current Ratio: 2.57%
  • Quick Ratio: 2.12%
Misc:
  • Average Volume: 156,277 shs.
  • Beta: 0.78
  • Short Ratio: 11.79
 

Frequently Asked Questions for Bio-Techne Corp (NASDAQ:TECH)

What is Bio-Techne Corp's stock symbol?

Bio-Techne Corp trades on the NASDAQ under the ticker symbol "TECH."

How often does Bio-Techne Corp pay dividends? What is the dividend yield for Bio-Techne Corp?

Bio-Techne Corp announced a quarterly dividend on Wednesday, August 9th. Shareholders of record on Friday, August 18th will be paid a dividend of $0.32 per share on Friday, September 1st. This represents a $1.28 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date is Wednesday, August 16th. View Bio-Techne Corp's Dividend History.

How were Bio-Techne Corp's earnings last quarter?

Bio-Techne Corp (NASDAQ:TECH) posted its quarterly earnings results on Tuesday, August, 8th. The company reported $1.09 EPS for the quarter, beating the Zacks' consensus estimate of $0.99 by $0.10. The firm earned $156.60 million during the quarter, compared to analyst estimates of $150.25 million. Bio-Techne Corp had a net margin of 12.93% and a return on equity of 14.19%. The firm's revenue was up 16.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 EPS. View Bio-Techne Corp's Earnings History.

When will Bio-Techne Corp make its next earnings announcement?

Bio-Techne Corp is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for Bio-Techne Corp.

Where is Bio-Techne Corp's stock going? Where will Bio-Techne Corp's stock price be in 2017?

5 brokerages have issued twelve-month price targets for Bio-Techne Corp's shares. Their predictions range from $122.00 to $132.00. On average, they anticipate Bio-Techne Corp's stock price to reach $126.33 in the next twelve months. View Analyst Ratings for Bio-Techne Corp.

Who are some of Bio-Techne Corp's key competitors?

Who are Bio-Techne Corp's key executives?

Bio-Techne Corp's management team includes the folowing people:

  • Robert V. Baumgartner CPA, Independent Chairman of the Board
  • Charles R. Kummeth, President, Chief Executive Officer, Director
  • Roger C. Lucas Ph.D., Independent Vice Chairman of the Board
  • James T. Hippel, Chief Financial Officer, Senior Vice President
  • Brenda S. Furlow J.D., Senior Vice President, General Counsel, Secretary
  • David Eansor, Senior Vice President - Biotechnology
  • Robert Gavin, Senior Vice President-Protein Platforms
  • Kevin S. Gould, Senior Vice President-Clinical Controls
  • J. Fernando Bazan Ph.D., Chief Technology Officer
  • Charles A. Dinarello M.D., Independent Director

Who owns Bio-Techne Corp stock?

Bio-Techne Corp's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.54%), Vanguard Group Inc. (8.15%), Atlanta Capital Management Co. L L C (5.25%), Neuberger Berman Group LLC (4.92%), Bamco Inc. NY (4.02%) and Janus Henderson Group PLC (3.18%). Company insiders that own Bio-Techne Corp stock include Charles A Dinarello, John L Higgins, Karen A Holbrook, Kevin S Gould, Robert V Baumgartner and Roger C Lucas. View Institutional Ownership Trends for Bio-Techne Corp.

Who sold Bio-Techne Corp stock? Who is selling Bio-Techne Corp stock?

Bio-Techne Corp's stock was sold by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Macquarie Group Ltd., Royce & Associates LP, Neuberger Berman Group LLC, Renaissance Technologies LLC, GSA Capital Partners LLP, Northern Trust Corp and Riverbridge Partners LLC. Company insiders that have sold Bio-Techne Corp stock in the last year include Charles A Dinarello, Karen A Holbrook and Roger C Lucas. View Insider Buying and Selling for Bio-Techne Corp.

Who bought Bio-Techne Corp stock? Who is buying Bio-Techne Corp stock?

Bio-Techne Corp's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, American Century Companies Inc., Koch Industries Inc., Schroder Investment Management Group, SG Capital Management LLC, Commonwealth Bank of Australia, Public Employees Retirement Association of Colorado and Lord Abbett & CO. LLC. View Insider Buying and Selling for Bio-Techne Corp.

How do I buy Bio-Techne Corp stock?

Shares of Bio-Techne Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bio-Techne Corp's stock price today?

One share of Bio-Techne Corp stock can currently be purchased for approximately $121.72.


MarketBeat Community Rating for Bio-Techne Corp (NASDAQ TECH)
Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  260
MarketBeat's community ratings are surveys of what our community members think about Bio-Techne Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bio-Techne Corp (NASDAQ:TECH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $126.33 (3.79% upside)

Analysts' Ratings History for Bio-Techne Corp (NASDAQ:TECH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/30/2017Deutsche Bank AGSet Price TargetBuy$132.00MediumView Rating Details
7/13/2017Wells Fargo & CompanyInitiated CoverageMarket Perform -> Market PerformLowView Rating Details
5/3/2017Citigroup Inc.Reiterated RatingBuy$115.00 -> $125.00LowView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralHighView Rating Details
11/10/2016Leerink SwannInitiated CoverageOutperform$122.00N/AView Rating Details
8/18/2016Robert W. BairdBoost Price TargetOutperform$115.00 -> $116.00N/AView Rating Details
11/2/2015Craig HallumLower Price TargetBuy$125.00 -> $110.00N/AView Rating Details
10/29/2015StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for Bio-Techne Corp (NASDAQ:TECH)
Earnings by Quarter for Bio-Techne Corp (NASDAQ:TECH)
Earnings History by Quarter for Bio-Techne Corp (NASDAQ TECH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017$0.88N/AView Earnings Details
8/8/2017Q4 2017$0.99$1.09$150.25 million$156.60 millionViewListenView Earnings Details
5/2/2017Q3 2017$0.93$0.97$142.83 million$144.04 millionViewListenView Earnings Details
2/7/2017Q217$0.85$0.81$134.74 million$131.80 millionViewListenView Earnings Details
10/31/2016Q117$0.79$0.84$127.47 million$130.60 millionViewListenView Earnings Details
8/17/2016Q416$0.96$0.92$129.23 million$134.80 millionViewListenView Earnings Details
5/3/2016Q316$0.89$1.01$122.65 million$131.00 millionViewN/AView Earnings Details
2/2/2016Q216$0.82$0.88$118.59 million$120.90 millionViewN/AView Earnings Details
10/28/2015Q1$0.85$0.79$116.91 million$12.40 millionViewListenView Earnings Details
8/6/2015Q415$0.86$0.87$116.85 million$117.70 millionViewN/AView Earnings Details
5/5/2015Q315$0.91$0.86$119.30 million$114.20 millionViewN/AView Earnings Details
2/3/2015Q215$0.86$0.89$112.73 million$111.90 millionViewN/AView Earnings Details
10/28/2014Q115$0.87$0.85$108.65 million$108.50 millionViewN/AView Earnings Details
8/11/2014Q414$0.85$0.88$91.80 million$92.50 millionViewN/AView Earnings Details
4/28/2014Q314$0.89$0.94$92.50 million$95.60 millionViewN/AView Earnings Details
2/4/2014Q214$0.80$0.75$84.79 million$84.00 millionViewN/AView Earnings Details
10/29/2013Q114$0.80$0.83$82.36 million$85.70 millionViewN/AView Earnings Details
8/6/2013Q4 2013$0.83$0.82$79.71 million$79.50 millionViewN/AView Earnings Details
4/30/2013Q3 2013$0.90$0.88$84.00 million$81.00 millionViewN/AView Earnings Details
2/5/2013Q2 2013$0.77$0.74$76.40 million$75.10 millionViewN/AView Earnings Details
10/23/2012$0.79$0.75ViewN/AView Earnings Details
7/31/2012$0.85$0.80ViewN/AView Earnings Details
5/1/2012$0.89$0.90ViewN/AView Earnings Details
1/31/2012$0.79$0.76ViewN/AView Earnings Details
10/25/2011$0.84$0.81ViewN/AView Earnings Details
8/2/2011$0.76$0.76ViewN/AView Earnings Details
5/3/2011$0.80$0.84ViewN/AView Earnings Details
2/1/2011$0.68$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Techne Corp (NASDAQ:TECH)
2017 EPS Consensus Estimate: $3.49
2018 EPS Consensus Estimate: $3.76
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.76$0.81$0.78
Q2 20173$0.81$0.85$0.83
Q3 20173$0.90$0.96$0.93
Q4 20173$0.93$0.98$0.95
Q1 20181$0.88$0.88$0.88
Q2 20182$0.82$0.89$0.86
Q3 20181$0.98$0.98$0.98
Q4 20182$1.02$1.07$1.05
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Bio-Techne Corp (NASDAQ:TECH)
Most Recent Dividend:9/1/2017
Annual Dividend:$1.28
Dividend Yield:1.05%
Payout Ratio:65.98% (Trailing 12 Months of Earnings)
34.41% (Based on This Year's Estimates)
31.22% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bio-Techne Corp (NASDAQ:TECH)

Dividend History by Quarter for Bio-Techne Corp (NASDAQ TECH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/9/2017Quarterly$0.321.1%8/16/20178/18/20179/1/2017
5/2/2017quarterly$0.321.15%5/17/20175/19/20176/2/2017
2/7/2017quarterly$0.321.27%2/15/20172/17/20173/3/2017
11/1/2016Quarterly$0.3211/9/201611/14/201611/28/2016
8/17/2016quarterly$0.328/25/20168/29/20169/12/2016
5/3/2016quarterly$0.321.27%5/11/20165/13/20165/27/2016
2/2/2016quarterly$0.321.48%2/10/20162/12/20162/26/2016
10/29/2015quarterly$0.321.45%11/10/201511/13/201511/27/2015
8/6/2015quarterly$0.321.18%8/13/20158/17/20158/28/2015
5/5/2015quarterly$0.321.31%5/11/20155/15/20155/29/2015
2/3/2015quarterly$0.321.4%2/11/20152/13/20152/27/2015
10/30/2014quarterly$0.321.41%11/6/201411/10/201411/24/2014
8/11/2014quarterly$0.311.31%8/19/20148/21/20148/29/2014
4/28/2014quarterly$0.311.37%5/7/20145/9/20145/23/2014
2/4/2014quarterly$0.311.48%2/12/20142/14/20142/28/2014
10/31/2013quarterly$0.311.4%11/7/201311/12/201311/25/2013
8/6/2013quarterly$0.301.62%8/14/20138/16/20138/31/2013
4/30/2013quarterly$0.301.86%5/8/20135/10/20135/24/2013
2/5/2013quarterly$0.301.74%2/13/20132/15/20133/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Bio-Techne Corp (NASDAQ:TECH)
Insider Ownership Percentage: 3.40%
Institutional Ownership Percentage: 98.43%
Insider Trades by Quarter for Bio-Techne Corp (NASDAQ:TECH)
Institutional Ownership by Quarter for Bio-Techne Corp (NASDAQ:TECH)
Insider Trades by Quarter for Bio-Techne Corp (NASDAQ:TECH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2017Roger C LucasDirectorSell100$120.94$12,094.00View SEC Filing  
9/6/2017Karen A HolbrookDirectorSell1,059$121.73$128,912.07View SEC Filing  
8/10/2017Roger C LucasDirectorSell100$114.30$11,430.00View SEC Filing  
7/10/2017Roger C LucasDirectorSell100$116.86$11,686.00View SEC Filing  
6/9/2017Roger C LucasDirectorSell100$113.62$11,362.00View SEC Filing  
5/31/2017Charles A DinarelloDirectorSell5,000$111.37$556,850.00View SEC Filing  
5/25/2017Karen A HolbrookDirectorSell5,000$111.15$555,750.00View SEC Filing  
5/10/2017Roger C LucasDirectorSell100$110.59$11,059.00View SEC Filing  
4/10/2017Roger C LucasDirectorSell100$101.15$10,115.00View SEC Filing  
1/10/2017Roger C LucasDirectorSell100$103.57$10,357.00View SEC Filing  
11/29/2016Karen A HolbrookDirectorSell1,000$106.73$106,730.00View SEC Filing  
11/16/2016Roger C LucasDirectorSell100$105.75$10,575.00View SEC Filing  
9/21/2016Roger C LucasDirectorSell100$108.91$10,891.00View SEC Filing  
9/8/2016John L HigginsDirectorSell1,700$109.83$186,711.00View SEC Filing  
9/8/2016Kevin S. GouldSVPSell524$110.50$57,902.00View SEC Filing  
9/2/2016Robert V BaumgartnerDirectorSell6,467$107.17$693,068.39View SEC Filing  
8/24/2016Robert V BaumgartnerDirectorSell3,533$107.10$378,384.30View SEC Filing  
8/17/2016Roger C. LucasDirectorSell100$113.70$11,370.00View SEC Filing  
7/20/2016Roger C LucasDirectorSell100$111.03$11,103.00View SEC Filing  
6/15/2016Roger C LucasDirectorSell100$112.15$11,215.00View SEC Filing  
5/18/2016Roger C LucasDirectorSell100$102.53$10,253.00View SEC Filing  
5/9/2016Charles A DinarelloDirectorSell5,000$101.91$509,550.00View SEC Filing  
5/6/2016Roger C LucasDirectorSell500$100.24$50,120.00View SEC Filing  
4/20/2016Roger C LucasDirectorSell100$92.40$9,240.00View SEC Filing  
3/16/2016Roger C LucasDirectorSell100$92.90$9,290.00View SEC Filing  
2/5/2016Roger C. LucasDirectorSell5,000$83.68$418,400.00View SEC Filing  
8/13/2015Roger C LucasDirectorSell5,000$106.01$530,050.00View SEC Filing  
6/8/2015Randolph C SteerDirectorSell1,000$99.39$99,390.00View SEC Filing  
2/19/2015Howard V OconnellDirectorSell5,000$95.78$478,900.00View SEC Filing  
12/10/2014Karen A HolbrookDirectorSell1,000$92.40$92,400.00View SEC Filing  
12/9/2014Kevin J ReaganVPSell3,591$89.35$320,855.85View SEC Filing  
12/8/2014Charles A DinarelloDirectorSell3,000$90.44$271,320.00View SEC Filing  
8/14/2014Karen A HolbrookDirectorSell5,000$95.54$477,700.00View SEC Filing  
5/7/2014Howard OconnellDirectorSell5,000$91.00$455,000.00View SEC Filing  
3/4/2014Karen HolbrookDirectorSell5,000$89.83$449,150.00View SEC Filing  
2/27/2014Randolph SteerDirectorSell5,000$88.78$443,900.00View SEC Filing  
11/13/2013Randolph SteerDirectorSell15,000$86.20$1,293,000.00View SEC Filing  
11/8/2013Robert BaumgartnerDirectorSell10,000$87.00$870,000.00View SEC Filing  
11/4/2013Roger C LucasDirectorSell10,000$87.64$876,400.00View SEC Filing  
5/6/2013Howard V OconnellDirectorBuy2,361$65.00$153,465.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Bio-Techne Corp (NASDAQ:TECH)
Latest Headlines for Bio-Techne Corp (NASDAQ:TECH)
Source:
DateHeadline
americanbankingnews.com logoBio-Techne Corp (TECH) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 16 at 8:34 AM
finance.yahoo.com logoETFs with exposure to Bio-Techne Corp. : September 14, 2017
finance.yahoo.com - September 14 at 11:05 AM
bizjournals.com logoBio-Techne CEO Charles Kummeth's compensation jumps to $9.1M
www.bizjournals.com - September 13 at 10:00 AM
finance.yahoo.com logoBio-Techne Introduces a New Luminex Multi-analyte Assay Kit
finance.yahoo.com - September 13 at 10:00 AM
americanbankingnews.com logoInsider Selling: Bio-Techne Corp (TECH) Director Sells 100 Shares of Stock
www.americanbankingnews.com - September 12 at 8:24 PM
finance.yahoo.com logoBio-Techne Corp. :TECH-US: Earnings Analysis: 2017 By the Numbers : September 11, 2017
finance.yahoo.com - September 12 at 10:47 AM
americanbankingnews.com logoContrasting Bio-Techne Corp (TECH) and its Competitors
www.americanbankingnews.com - September 12 at 12:28 AM
americanbankingnews.com logoKaren A. Holbrook Sells 1,059 Shares of Bio-Techne Corp (TECH) Stock
www.americanbankingnews.com - September 8 at 8:40 PM
finance.yahoo.com logoFeatured Company News - Bio-Techne Acquires Trevigen in an All-cash Deal
finance.yahoo.com - September 8 at 9:12 AM
finance.yahoo.com logoBio-Techne Releases A Highly Sensitive and Specific Serological Assay to Detect Zika Virus Infections
finance.yahoo.com - September 7 at 9:46 AM
reuters.com logoBRIEF-Bio-Techne acquires Trevigen Inc
www.reuters.com - September 6 at 9:06 AM
seekingalpha.com logoBio-Techne buys Trevigen in all-cash deal
seekingalpha.com - September 6 at 7:35 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Techne Corporation - TECH
finance.yahoo.com - August 31 at 10:51 AM
americanbankingnews.com logoDeutsche Bank AG Reiterates $132.00 Price Target for Bio-Techne Corp (TECH)
www.americanbankingnews.com - August 30 at 10:34 PM
finance.yahoo.com logoBio-Techne To Present At The Wells Fargo Healthcare Conference
finance.yahoo.com - August 29 at 8:33 AM
americanbankingnews.com logo Brokerages Anticipate Bio-Techne Corp (TECH) Will Post Quarterly Sales of $142.75 Million
www.americanbankingnews.com - August 26 at 7:26 PM
americanbankingnews.com logoBio-Techne Corp (TECH) Upgraded by BidaskClub to Buy
www.americanbankingnews.com - August 24 at 12:14 AM
americanbankingnews.com logoBio-Techne Corp to Post FY2019 Earnings of $3.99 Per Share, William Blair Forecasts (TECH)
www.americanbankingnews.com - August 23 at 3:22 PM
finance.yahoo.com logoBio-Techne To Present At The Baird 2017 Global Healthcare Conference
finance.yahoo.com - August 23 at 12:28 PM
americanbankingnews.com logoWilliam Blair Weighs in on Bio-Techne Corp's FY2018 Earnings (TECH)
www.americanbankingnews.com - August 22 at 1:58 PM
americanbankingnews.com logoBio-Techne Corp (TECH) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 22 at 8:34 AM
finance.yahoo.com logoGoogle's Alphabet passes Facebook as hedge fund favorite
finance.yahoo.com - August 20 at 11:05 PM
finance.yahoo.com logoBio-Techne Corp. – Value Analysis (NASDAQ:TECH) : August 19, 2017
finance.yahoo.com - August 19 at 8:09 AM
finance.yahoo.com logoCorporate News Blog - Exelixis Submits US Supplemental New Drug Application for CABOMETYX(R) for the Treatment of Previously Untreated Advanced Kidney Cancer
finance.yahoo.com - August 18 at 7:47 AM
americanbankingnews.com logoBio-Techne Corp (TECH) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - August 15 at 11:16 AM
americanbankingnews.com logoRoger C. Lucas Sells 100 Shares of Bio-Techne Corp (NASDAQ:TECH) Stock
www.americanbankingnews.com - August 15 at 12:16 AM
americanbankingnews.com logoBio-Techne Corp Forecasted to Post Q2 2018 Earnings of $0.82 Per Share (TECH)
www.americanbankingnews.com - August 14 at 7:38 AM
americanbankingnews.com logoBio-Techne Corp (TECH) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - August 12 at 7:54 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Bio-Techne Corp.
finance.yahoo.com - August 10 at 9:31 PM
finance.yahoo.com logoBio-Techne (TECH) Beats Earnings, Revenue Estimates in Q4
finance.yahoo.com - August 10 at 4:28 PM
americanbankingnews.com logoBio-Techne Corp Declares Quarterly Dividend of $0.32 (TECH)
www.americanbankingnews.com - August 10 at 2:20 PM
reuters.com logoBRIEF-Bio-Techne Q4 adjusted earnings per share $1.09
www.reuters.com - August 10 at 8:40 AM
americanbankingnews.com logoBio-Techne Corp (TECH) PT Raised to $132.00 at Deutsche Bank AG
www.americanbankingnews.com - August 9 at 2:08 PM
finance.yahoo.com logoBio-Techne Releases Fourth Quarter Fiscal 2017 Results
finance.yahoo.com - August 9 at 8:08 AM
finance.yahoo.com logoBio-Techne Corp. breached its 50 day moving average in a Bullish Manner : TECH-US : August 8, 2017
finance.yahoo.com - August 9 at 8:08 AM
finance.yahoo.com logoEdited Transcript of TECH earnings conference call or presentation 8-Aug-17 1:00pm GMT
finance.yahoo.com - August 9 at 8:08 AM
americanbankingnews.com logoBio-Techne Corp (NASDAQ:TECH) Issues Quarterly Earnings Results
www.americanbankingnews.com - August 8 at 1:52 PM
americanbankingnews.com logoZacks: Analysts Expect Bio-Techne Corp (NASDAQ:TECH) Will Post Quarterly Sales of $149.49 Million
www.americanbankingnews.com - August 7 at 7:44 AM
americanbankingnews.com logoBio-Techne Corp (TECH) Downgraded by BidaskClub
www.americanbankingnews.com - August 5 at 10:58 AM
zacks.com logoShould You Buy Bio-Techne (TECH) Ahead of Earnings?
www.zacks.com - August 4 at 8:55 AM
finance.yahoo.com logoETFs with exposure to Bio-Techne Corp. : August 1, 2017
finance.yahoo.com - August 2 at 7:41 AM
americanbankingnews.com logoBio-Techne Corp (TECH) to Release Earnings on Tuesday
www.americanbankingnews.com - August 1 at 7:31 AM
americanbankingnews.com logoBio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - July 28 at 8:29 AM
americanbankingnews.com logoBio-Techne Corp (TECH) Lowered to Hold at BidaskClub
www.americanbankingnews.com - July 16 at 9:32 PM
americanbankingnews.com logoBio-Techne Corp (TECH) Expected to Announce Quarterly Sales of $149.49 Million
www.americanbankingnews.com - July 16 at 7:54 AM
americanbankingnews.com logoZacks: Analysts Expect Bio-Techne Corp (NASDAQ:TECH) Will Announce Earnings of $0.90 Per Share
www.americanbankingnews.com - July 14 at 10:28 PM
finance.yahoo.com logoETFs with exposure to Bio-Techne Corp. : July 13, 2017
finance.yahoo.com - July 14 at 9:03 AM
finance.yahoo.com logoBio-Techne To Host Conference Call On August 8, 2017 To Announce Fourth Quarter Financial Results
finance.yahoo.com - July 13 at 10:16 AM
americanbankingnews.com logoBio-Techne Corp (TECH) Director Roger C. Lucas Sells 100 Shares
www.americanbankingnews.com - July 12 at 8:44 PM
americanbankingnews.com logoBio-Techne Corp (NASDAQ:TECH) Upgraded at Zacks Investment Research
www.americanbankingnews.com - July 6 at 2:00 PM

Social

Chart

Bio-Techne Corp (TECH) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff